Dr Paweł Żero from Celon Pharma completed his secondment at UCT Prague, conducted under the auspices of the EU project ORBIS. His work focused on solubility enhancement strategies for a new active compound currently in development at Celon. We would like to thank Paweł for his visit and we are looking forward to further collaboration.